Gilead Sciences Inc. (GILD): Growing Popularity as Defensive Stock

Gilead Sciences, Inc. (NASDAQ:GILD) has transitioned distant from its volatile COVID-19 attraction gross from Veklury. The halfway concern successful HIV and a increasing oncology pipeline supply the steadfast with high-visibility, non-discretionary earnings. The antiaircraft spot is the ascendant presumption successful the HIV market, which functions likewise to a inferior due to the fact that the treatments are life-sustaining and non-discretionary. Gilead’s HIV portfolio generated $20.8 cardinal successful 2025. Patients seldom power treatments erstwhile stabilized, creating a highly predictable currency travel that is unaffected by broader economical cycles. During the Barclays Healthcare Conference successful March, CFO Andrew Dickinson emphasized that Gilead faces nary large nonaccomplishment of exclusivity until 2036. This runway provides a level of information that is uncommon successful the pharma sector. Yeztugo, the archetypal twice-yearly HIV prevention therapy, is expected to deed $800 cardinal successful income successful 2026.

READ MORE: 10 Best Stocks to Buy According to Billionaire Paul Tudor Jones.

Gilead Sciences, Inc. (NASDAQ:GILD) banal is simply a favourite for income-focused funds due to the fact that of its assertive currency instrumentality to shareholders. In February, the committee raised the quarterly dividend to $0.82 per share, marking different twelvemonth of consecutive growth. As of April, the guardant dividend output stands astatine astir 2.4%, backed by a steadfast non-GAAP EPS guidance of $8.45–$8.85 for the afloat year. To bolster its antiaircraft profile, Gilead has spent the past 5 years diversifying into oncology, which present accounts for astir 12% of full revenue. Products similar Trodelvy and compartment therapies are seeing double-digit growth. This provides a maturation kicker connected apical of the antiaircraft HIV base, diversifying the company’s hazard crossed antithetic therapeutic areas.

While we admit the imaginable of GILD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: Israel Englander Stock Portfolio: Top 10 Stock Picks and Billionaire Stan Druckenmiller’s 10 Small and Mid-Cap Stock Picks with Huge Upside Potential.

Disclosure: None. Follow Insider Monkey connected Google News.